Aaron Roller is an Ophthalmology physician. OpenAlex indexes 17 publications with 214 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
801 W 38th St Ste 200
Austin, TX 787051169
Telephone
512-451-0103Provider last certified this registry record 3 Nov 2022.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Digital Diagnostics Inc.Program year20251 payment$48,000openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- Astellas Pharma US IncProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
80.2%Antineovascularisation agents71.9%Faricimab-svoa100%Part B, office-administered≥66 patientsComplement Inhibitor6.4%Avacincaptad pegol100%Part B, office-administered≥25 patients+ 5 more classes in this area
Cancer & immunology
19.3%Vascular Endothelial Growth Factor Inhibitor11.3%Aflibercept92%Bevacizumab8%Part B, office-administered≥299 patientsComplement Inhibitor8%Pegcetacoplan100%Part B, office-administered≥28 patientsCardiovascular
0.4%Beta blocker0.4%Timolol Maleate100%Part D≥34 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- HEMORRHAGIC VASCULITIS AND RETINOPATHY HERALDING AS AN EARLY SIGN OF BACTERIAL ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION
Retinal Cases & Brief Reports
2017 - Long term follow-up of acute multifocal hemorrhagic retinal vasculitis (Blumenkranz syndrome): case report
Arquivos Brasileiros de Oftalmologia
2011
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”